Navigation Links
Boffins a Step Closer to Solving Puzzle of Lou Gehrig's Disease

Moving closer to solving Lou Gehrig's disease mystery, UCLA, Italian chemists may have solved an important mystery about a protein that plays a key role in a particular form of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, a progressive, fatal neuro-degenerative disorder that strikes without warning.

Joan Selverstone Valentine, UCLA professor of chemistry and biochemistry, has studied the protein copper-zinc superoxide dismutase since the 1970s, long before it was implicated in ALS in 1993.

Since the link was discovered, Valentine's laboratory has made more than two dozen mutant, ALS-causing enzymes, most of which have only one wrong amino acid out of 153, to try to understand their properties and learn what makes them toxic.

"Some of the mutant proteins are very different from the normal protein, but others are virtually identical to the normal protein - yet they all cause the disease," said Valentine, a member of UCLA's Molecular Biology Institute.

"That was the real mystery. You wrack your brain: What is similar among all these proteins" They seem so different. How can they all cause the same disease," he added.

Now Valentine and her colleagues, including Ivano Bertini, professor of chemistry at the University of Florence and director of the European Magnetic Resonance Center, think they know. In ALS patients, the protein's copper and zinc may not be there at all.

"If we keep the metals entirely out of the protein, we can explain the toxicity, since even the normal protein forms aggregate at physiological conditions when the metals are gone. It was such a puzzle, but this hypothesis can solve it," Valentine said

"If scientists can figure out why ALS patients lack the copper and zinc, that would be a major advance that could lead to treatment," she said.

Copper-zinc superoxide dismutase, which was discovered in the 1960s, is
'"/>




Page: 1 2 3

Related medicine news :

1. Fizzy Logic For A Perfect Drink: Courtesy Boffins
2. Boffins Identify Fifth Gene Behind Joubert Syndrome
3. Boffins Find Link Between Common Sleep Disorder and Hypertension
4. Boffins Identify Molecule That Might Treat Food Allergy
5. Boffins Identify Gene That Helps Regulates Body Weight
6. Boffins Link Atkins Diet With Bowel Cancer
7. Boffins Develop New Technique to Hunt Illness-causing Mutants in Non-gene DNA
8. A Closer Look into Vitamin D and Fractures
9. Scientists Closer To Identifying Gene Connected To Alzheimers
10. Scientist Move A Step Closer To Treating Genetic Obesity
11. Chlamydia Vaccine a Step Closer to Reality

Post Your Comments:
(Date:11/30/2009)... Peter J. Rappa, MD, explores the intricat...new book "Healing Heart to Soul: One Doctor&r...(Brown Books 2009). , Dal... and refusing to let go of negative emotions, whet... heavy on our shoulders. Oftentimes, this disease ...
(Date:11/30/2009)..., SHENZHEN, China, Nov. 30 /PRNewswire-FirstCall/...medical.com/ ) operating subsidiary Mellow Hope fi...anufacturer of intravenous medication in India. Th...es for Hard to Treat Diseases in the following qua...ian company secures the supply of raw pharmaceutic...
(Date:11/30/2009)...ENGLEWOOD, Colo., Nov. 30 Baxa Cor... discussing what "culture of safety" means in toda...esentation, "Creating a Culture of Safety in Phar...onals discussing their experiences with culture of...y in pharmacy and the role of technology in enabli...
(Date:11/30/2009)... Red Cross offers online giving catalog to help fa... ,, WASHINGTON, Nov. 30 /PRNewswire-USNewswir... are entering this holiday season willing to suppo... to dig deep into their own wallets to support cha...bout donating to charity instead of buying them a ...
(Date:11/30/2009)...KLAND, Mass., Nov. 30 EMD Serono, ...nounced today that it received a refuse to file le...) on the New Drug Application (NDA) for Cladribine... oral formulation of cladribine, as a therapy for ... "The company will work closely with the FDA to fu...
Breaking Medicine News(10 mins):Health News:Healing from the Inside Out: Compelling New Book Explores the Intricate Connection between Body, Soul, and Better Health 2Health News:Hard to Treat Diseases (HTDS) Closes 1 Million Dollar Contract Indian Pharmaceutical 2Health News:Hard to Treat Diseases (HTDS) Closes 1 Million Dollar Contract Indian Pharmaceutical 3Health News:Baxa to Sponsor ASHP Midday Symposium: Creating a Culture of Safety in Pharmacy, A Panel Discussion on Lessons Learned 2Health News:Baxa to Sponsor ASHP Midday Symposium: Creating a Culture of Safety in Pharmacy, A Panel Discussion on Lessons Learned 3Health News:American Red Cross Survey Finds 62 Percent of Americans Plan to Donate More Than $25 to Charity This Holiday Season in Spite of Economic Downturn 2Health News:American Red Cross Survey Finds 62 Percent of Americans Plan to Donate More Than $25 to Charity This Holiday Season in Spite of Economic Downturn 3Health News:EMD Serono Receives Refuse to File Letter from FDA on Cladribine Tablets New Drug Application 2Health News:EMD Serono Receives Refuse to File Letter from FDA on Cladribine Tablets New Drug Application 3
...chester Medical Center (URMC) announced today that... developer and philanthropist Richard T. Fields fo...largest private donation for a specific disease pr...cular dystrophy. , The new Fields Center for FSHD...
...he University of Michigan is the lead research ins...tium to study the health consequences on victims i...al Center for Disaster Mental Health Research, inc... is funded by the National Institutes of Health. ,...
...r blow to Trasylol, used to cut down on bleeding d...5 (HealthDay News) -- The U.S. Food and Drug Admin...ty of the clotting drug aprotinin (Trasylol), afte... the FDA in 1993, is typically used to limit blood...
...ME (BioMedical Enterprises, Inc.),today announced ... Medical,Director, was elected to BME,s Board of D...excelled in his leadership as,Medical Director of ...e to the BOD over this year has demonstrated,his i...
...venue, Net Income and EPS; Revenue, Net...., Oct. 25 MICROS Systems, Inc.,(Nasdaq: MCRS ),...hospitality and retail industries, today announced...rease of $42.8 million, or 24.6%, over the sam...
...s to switch the wrigglers, orientation , THURSDAY,...hard-wired into the brains of small worms called n...ed some of the creatures to make them attracted to...y are about worms and how attraction behaviors are...
Other Medicine News:Health News:New center to lead international muscular dystrophy research effort 2Health News:New center to lead international muscular dystrophy research effort 3Health News:New center to lead international muscular dystrophy research effort 4Health News:U-M to lead disaster aftermath research center 2Health News:FDA to Review Clotting Drug After Trial Suggests Death Risk 2Health News:FDA to Review Clotting Drug After Trial Suggests Death Risk 3Health News:FDA to Review Clotting Drug After Trial Suggests Death Risk 4Health News:MICROS Reports Fiscal 2008 First Quarter Results 2Health News:MICROS Reports Fiscal 2008 First Quarter Results 3Health News:MICROS Reports Fiscal 2008 First Quarter Results 4Health News:MICROS Reports Fiscal 2008 First Quarter Results 5Health News:MICROS Reports Fiscal 2008 First Quarter Results 6Health News:MICROS Reports Fiscal 2008 First Quarter Results 7Health News:Worm Study Points to Sexuality's Origins 2
(Date:11/30/2009)...v. 30 Dr. Jocelyn Rapelyea, Associ... George Washington University Medical Center in Wa...entified with Breast-Specific Gamma Imaging (BSGI)... for needle biopsy as well, as for pre-operative l...iological Society of North America (RSNA). ,, B...
(Date:11/30/2009)...HAM, Mass., Nov. 30 According to M...ty on medical technology market intelligence, the ...t declined by almost 5% over 2008 as patients chos...economic crisis. The market will, however, begin r...trong pre-recession growth rates of over 15%. MRG,...
(Date:11/30/2009)...Nov. 30 MedPro Imaging, a premium ...ns, will showcase leading ultrasound solutions inc...ns X300 Premium Edition during the company,s debut...SNA) conference, being held in Chicago November 29...g markets ultrasound products and services in 17 c...
Breaking Medicine Technology:Breast-Specific Gamma Imaging Identifies Occult Lesions Using Multi-Modality Imaging for Biopsy 2Facial Injectables Emerge From the Recession 2Facial Injectables Emerge From the Recession 3MedPro Imaging to Showcase Leading New and Refurbished Ultrasound Solutions at RSNA 2ERT to Present at Bairds 2009 Health Care Conference on September 9 2009 13778 1ERT to Present at Bairds 2009 Health Care Conference on September 9 2009 13778 2San Francisco Health Plan Recognized as Top Health Plan for Quality in the California Medi Cal Program 55899 1San Francisco Health Plan Recognized as Top Health Plan for Quality in the California Medi Cal Program 55899 2San Francisco Health Plan Recognized as Top Health Plan for Quality in the California Medi Cal Program 55899 3Employers Launch Grassroots Health Reform Coalition 55895 1Employers Launch Grassroots Health Reform Coalition 55895 2Employers Launch Grassroots Health Reform Coalition 55895 3
...07-Preliminary results from,the immunotherapeutic ...nter show a very good safety profile for SBG. Furt...nt have been observed,among several patients that ... monoclonal antibody against neuroblastoma. , In l...report for,the 1st quarter 2007, all 24 patients h...
...ional Myeloma Workshop held in,Kos, Greece demonst...on with bortezomib, dexamethasone and lenalidomide...ractory multiple,myeloma, and as a single agent in...acroglobulinemia, NEW YORK, June 29, 2007 /PRNewsw...oday announced that 4 posters were,presented at th...
Other Medicine Technology:Biotec Pharmacon Announces Preliminary Results from the,Sloan-Kettering Clinical Study 2Biotec Pharmacon Announces Preliminary Results from the,Sloan-Kettering Clinical Study 3Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 2Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 3Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 4Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 5Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 6Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 7
... a new level of immunodiagnostic productivity. Opt...h any laboratory automation system. No-pause loadi...e only immunoassay system with this capability. No...thout any additional setup. Continuous sample load...
... random access operation, the Elecsys 2010 System ...ories that want to maximize productivity and effic...ity and Stat capabilities of the Elecsys 1010 syst...f an aggressive laboratory testing environment. It...
Dimension RxL Max w/o HM 50/60 HZ
Modular Analytics E 170 Module
Medicine Products: